Kovid-19 salg\u0131n\u0131 s\u00fcrecinde bir\u00e7ok \u00fclke, yayg\u0131n a\u015f\u0131lama<\/strong> programlar\u0131nda kullan\u0131lmak \u00fczere milyonlarca dozluk a\u015f<\/strong>\u0131<\/strong> i\u00e7in kesenin a\u011fz\u0131n\u0131 a\u00e7t\u0131.<\/p>\n

BioNTech ve Pfizer, Kovid-19 a\u015f\u0131s\u0131 i\u00e7in, Avrupa Birli\u011fi\u2019nden (AB) 300 milyon doz, ABD\u2019den 200 milyon doz, Kovid-19 A\u015f\u0131lar\u0131 Global Eri\u015fim Program\u0131\u2019ndan (COVAX) 40 milyon doz dahil toplamda 780 milyon doz sipari\u015f ald\u0131.<\/p>\n

The Guardian\u2019\u0131n haberine nazaran, BioNTech ile maliyetleri ve karlar\u0131n\u0131 e\u015fit olarak b\u00f6len Pfizer, mevcut mutabakatlara dayal\u0131 olarak 2021’de 15 milyar dolarl\u0131k sat\u0131\u015f bekliyor. \u015eirketler bu y\u0131l 2 milyar doz tedarik edebilecek kapasitede oldu\u011funu bildirdikleri i\u00e7in toplam sat\u0131\u015f\u0131n 30 milyar dolara kadar \u00e7\u0131kabilece\u011fi \u00f6ng\u00f6r\u00fcl\u00fcyor.<\/p>\n

\u00d6b\u00fcr \u015firketlere g\u00f6re daha esasl\u0131 bir \u015firket olan Pfizer\u2019in (kurulu\u015f tarihi 1849) paylar\u0131 son 12 ayda y\u00fczde 1,8 artarken, BioNTech paylar\u0131 ise y\u00fczde 156 artt\u0131.<\/p>\n

ABD\u2019li Moderna ise yapt\u0131\u011f\u0131 mutabakatlarla Pfizer-BioNTech\u2019in akabinde geliyor. \u015eirket, AB\u2019den 2021\u2019de 310 milyon, 2022\u2019de de 150 milyon olmak \u00fczere toplamda 460 milyon doz sipari\u015f al\u0131rken, ABD\u2019den 300 milyon, Japonya\u2019dan da 50 milyon doz sipari\u015f ald\u0131.<\/p>\n

Moderna\u2019dan yap\u0131lan a\u00e7\u0131klamada, 2021’de 18,4 milyar dolarl\u0131k sat\u0131\u015f beklendi\u011fi bildirildi. 11 y\u0131l evvel kurulan \u015firketin paylar\u0131 ise son 12 ayda y\u00fczde 372 artt\u0131.<\/p>\n

Merkezi ABD’de bulunan Johnson & Johnson’\u0131n Bel\u00e7ika’daki ba\u011fl\u0131 \u015firketi Janssen, \u00fcretti\u011fi tek dozluk Kovid-19 a\u015f\u0131s\u0131 ile ABD ve \u0130ngiltere\u2019den 52 milyon doz, AB\u2019den 400 milyon doz, COVAX\u2019tan ise 2022\u2019ye kadar 500 milyon doz a\u015f\u0131 sipari\u015fi ald\u0131.<\/p>\n

Bu y\u0131l sonuna kadar 1 milyar doz a\u015f\u0131 teslim edecek kapasitesi oldu\u011funu bildiren \u015firketin paylar\u0131 son 12 ayda y\u00fczde 7,7 paha kazand\u0131. Janssen’in 2021\u2019de 10 milyar dolarl\u0131k sat\u0131\u015f yapmas\u0131 bekleniyor.<\/p>\n

\u0130ngiliz-\u0130sve\u00e7 ila\u00e7 firmas\u0131 AstraZeneca da Oxford \u00dcniversitesi ile geli\u015ftirdi\u011fi a\u015f\u0131ya, AB\u2019den 400 milyon doz, ABD\u2019den 300 milyon doz, Japonya\u2019dan 120 milyon doz, \u0130ngiltere\u2019den 100 milyon doz sipari\u015f ald\u0131. 2021\u2019de 3 milyar dolarl\u0131k sat\u0131\u015f yapmas\u0131 \u00f6ng\u00f6r\u00fclen \u015firket, iki dozluk a\u015f\u0131 i\u00e7in 10 dolar \u00fczere d\u00fc\u015f\u00fck bir fiyat belirledi. \u015eirketin paylar\u0131 ise ba\u015fka \u015firketlerin tersine son 12 ayda y\u00fczde 8,6 bedel kaybetti.<\/p>\n

\u00c7inli ila\u00e7 \u015firketi Sinovac taraf\u0131ndan geli\u015ftirilen a\u015f\u0131 ise ba\u015fta T\u00fcrkiye olmak \u00fczere, Brezilya, \u015eili, Singapur, Malezya ve Filipinler \u00fczere \u00fclkelerde onaylanarak kullan\u0131lmaya ba\u015fland\u0131. COVAX \u00fclkelerine de 10 milyon doz a\u015f\u0131 sa\u011flamay\u0131 planlayan \u015firketin sat\u0131\u015flar\u0131 net olarak bilinmezken milyarlarca dolarl\u0131k sat\u0131\u015f yapmas\u0131 \u00f6ng\u00f6r\u00fcl\u00fcyor. Sinovac\u2019\u0131n paylar\u0131 de son 12 ayda y\u00fczde 21,6 bedel kaybetti.<\/p>\n

Rus Gamaleya Enstit\u00fcs\u00fcn\u00fcn a\u015f\u0131s\u0131, ABD\u2019li Novavax ve Alman CureVac ila\u00e7 \u015firketlerinin \u00fcretti\u011fi a\u015f\u0131lar da y\u00fcz milyonlarca doz a\u015f\u0131 sipari\u015fi al\u0131rken \u015firketlerin toplam sat\u0131\u015flar\u0131na ait bilgilere ula\u015f\u0131lamad\u0131.<\/p>\n

Novavax, a\u015f\u0131 \u00fcreticileri ortas\u0131nda son 12 ayda y\u00fczde 1128 art\u0131\u015f ile paylar\u0131 en \u00e7ok k\u0131ymetlenen \u015firket oldu.<\/p>\n<\/p>\n

Bloomberg HT<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Kovid-19 salg\u0131n\u0131 s\u00fcrecinde bir\u00e7ok \u00fclke, yayg\u0131n a\u015f\u0131lama programlar\u0131nda kullan\u0131lmak \u00fczere milyonlarca dozluk a\u015f\u0131 i\u00e7in kesenin a\u011fz\u0131n\u0131 a\u00e7t\u0131 …<\/p>\n","protected":false},"author":1,"featured_media":26480,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[46,196,226],"class_list":["post-26479","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ekonomi","tag-abd","tag-asi","tag-doz"],"yoast_head":"\n